Grimm Thomas L 4

What Happened

• Thomas L. Grimm, a director of Marathon Bancorp, was granted awards on 2026-06-15 consisting of 3,386 restricted shares (acquired, $0.00 per share) and 8,467 derivative shares (acquired, $0.00 per share). Both transactions are reported as code "A" (award/grant) on the Form 4; total cash paid was $0. These are grants, not purchases or sales.

Key Details

• Transaction date: 2026-06-15; Form 4 filed: 2026-06-16 (timely).
• Price: $0.00 per share for both the restricted and derivative awards.
• Shares acquired: 3,386 (restricted stock) + 8,467 (derivative instrument) — total 11,853 awarded.
• Shares owned after transaction: not disclosed in the provided excerpt of the filing.
• Footnotes (vesting/terms):
  • F1: Restricted shares vest 20% per year beginning June 15, 2027.
  • F2: Includes restricted shares vesting 20% per year beginning June 28, 2023.
  • F3–F5: Various stock-option vesting schedules (20% per year) commencing on June 15, 2027; June 28, 2023; and May 16, 2024, respectively.
• Filing timeliness: Report appears timely (filed one day after transaction date).

Context

• These awards were granted as compensation (code A) and are not open‑market purchases or sales; they do not by themselves signal a buy/sell decision by the insider.
• The 8,467 "derivative" shares indicate an award structured as a derivative instrument (e.g., RSUs or option-based rights) that will convert to stock subject to the vesting schedules noted in the footnotes.
• For retail investors: awards and vesting schedules are common for directors; consider them alongside broader insider activity and company fundamentals rather than as standalone buy/sell signals.